Background: Hypovitaminosis D and a low calcium intake contribute to increased parathyroid function in elderly persons. Calcium and vitamin D supplements reduce this secondary hyperparathyroidism, but whether such supplements reduce the risk of hip fractures among elderly people is not known.
Methods: We studied the effects of supplementation with vitamin D₃ (cholecalciferol) and calcium on the frequency of hip fractures and other nonvertebral fractures, identified radiologically, in 3270 healthy ambulatory women (mean [±SD] age, 84±6 years). Each day for 18 months, 1634 women received tricalcium phosphate (containing 1.2 g of elemental calcium) and 20 μg (800 IU) of vitamin D₃, and 1636 women received a double placebo. We measured serial serum parathyroid hormone and 25-hydroxyvitamin D (25(OH)D) concentrations in 142 women and determined the femoral bone mineral density at base line and after 18 months in 56 women.
Results: Among the women who completed the 18-month study, the number of hip fractures was 43 percent lower (P = 0.043) and the total number of nonvertebral fractures was 32 percent lower (P = 0.015) among the women treated with vitamin D₃ and calcium than among those who received placebo. The results of analyses according to active treatment and according to intention to treat were similar. In the vitamin D₃—calcium group, the mean serum parathyroid hormone concentration had decreased by 44 percent from the base-line value at 18 months (P<0.001) and the serum 25(OH)D concentration had increased by 162 percent over the base-line value (P<0.001). The bone density of the proximal femur increased 2.7 percent in the vitamin D₃—calcium group and decreased 4.6 percent in the placebo group (P<0.001).
Conclusions: Supplementation with vitamin D₃ and calcium reduces the risk of hip fractures and other nonvertebral fractures among elderly women.
|1998||Greenspan SL, Myers ER, Kiel DP, Parker RA, Hayes WC, Resnick NM. Fall direction, bone mineral density, and function: risk factors for hip fracture in frail nursing home elderly. Am J Med. June 1998;104(6):539-545.|
|2006||Hadjidakis DJ, Androulakis II. Bone remodeling. Annals NY Acad Sci. December 2006;1092(1):385-396.|
|1995||Riggs BL, Melton LJ III. The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone. November 1995;17(5)(suppl 1):S505-S511.|
|2020||Chakhtoura M, Chamoun N, Rahme M, Fuleihan GE-H. Impact of vitamin D supplementation on falls and fractures: a critical appraisal of the quality of the evidence and an overview of the available guidelines. Bone. February 2020;131.|
|1993||Cooper C. The epidemiology of fragility fractures: is there a role for bone quality? Calcif Tiss Int. February 1993;53(suppl 1):S23-S26.|
|1999||Parkkari J, Kannus P, Palvanen M, Natri A, Vainio J, Aho H, Vuori I, Järvinen M. Majority of hip fractures occur as a result of a fall and impact on the greater trochanter of the femur: a prospective controlled hip fracture study with 206 consecutive patients. Calcif Tiss Int. July 1999;65(3):183-187.|
|2020||Sami A, Abrahamsen B. The latest evidence from vitamin d intervention trials for skeletal and non-skeletal outcomes. Calcif Tiss Int. January 2020;106(1):88-93.|
|2020||Thompson MJW, Jones G, Balogun SA, Aitken DA. Skin photosensitivity is associated with 25-hydroxyvitamin D and BMD but not fractures independent of melanin density in older caucasian adults. Calcif Tiss Int. October 2020;107(4):335-344.|
|2011||Cole JH, van der Meulen MCH. Whole bone mechanics and bone quality. Clin Orthop Relat Res. August 2011;469(8):2139-2149.|
|2002||Riggs BL, Khosla S, Melton LJ III. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev. June 2002;23(3):279-302.|
|1999||Ota T, Yamamoto I, Morita R. Fracture simulation of the femoral bone using the finite-element method: how a fracture initiates and proceeds. J Bone Min Metab. May 1999;17(2):108-112.|
|1996||Garnero P, Hausherr E, Chapuy M, Marcelli C, Grandjean H, Muller C, Cormier C, Bréart G, Meunier PJ, Delmas PD. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J Bone Miner Res. October 1996;11(10):1531-1538.|
|1998||Riggs BL, Khosla S, Melton LJ III. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res. May 1998;13(5):763-773.|
|2000||Faulkner KG. Bone matters: are density increases necessary to reduce fracture risk? J Bone Miner Res. February 2000;15(2):183-187.|
|2020||LeBoff MS, Chou SH, Murata EM, Donlon CM, Cook NR, Mora S, Lee I, Kotler G, Bubes V, Buring JE, Manson JE. Effects of supplemental vitamin D on bone health outcomes in women and men in the VITamin D and OmegA‐3 TriaL (VITAL). J Bone Miner Res. May 2020;35(5):883-893.|
|1996||Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet. December 7, 1996;348(9041):1535-1541.|
|2006||Sambrook P, Cooper C. Osteoporosis. Lancet. June 17, 2006;367(9527):2010-2018.|
|1995||Liberman UA, Weiss SR, Bröll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW Jr, Dequeker J, Favus M, Seeman E, Recker RR, Capizzi T, Santora AC, Lombardi A, Shah RV, Hirsch LJ, Karpf DB; Group APIOTS. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. NEJM. November 30, 1995;333(22):1437-1443.|
|2001||Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster J-Y, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mellström D, Oefjord ES, Marcinowska-Suchowierska E, Salmi J, Mulder H, Halse J, Sawicki AZ, Mitlak BH. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. NEJM. May 10, 2001;344(19):1434-1441.|
|1994||Kanis JA; WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporos Int. November 1994;4(6):368-381.|
|1997||Who are candidates for prevention and treatment for osteoporosis? Osteoporos Int. January 1997;7(1):1-6.|
|2020||Aul AJ, Dudenkov DV, Mara KC, Juhn YJ, Wi CI, Maxson JA, Thacher TD. The relationship of 25-hydroxyvitamin D values and risk of fracture: a population-based retrospective cohort study. Osteoporos Int. September 2020;31(9):1787-1799.|
|2013||Burket JC. Alterations in Tissue Composition and Nanomechanical Properties With Ageing, Osteoporosis, and Treatment [PhD thesis]. Ithaca, NY: Cornell University; January 2013.|
|2005||Murray AW. Fracture Healing in Osteopenic Bone and the Influence of Simvastatin [MD thesis]. University of Edinburgh; 2005.|
|2009||Nakade R. Influence of Interfacial Properties and Inhomogeneity on Formation of Microdamage in Bone [Master's thesis]. San Antionio, TX: University of Texas at San Antonio; December 2009.|